Indomethacin - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for indomethacin and what is the scope of freedom to operate?
Indomethacin
is the generic ingredient in six branded drugs marketed by Zyla, Able, Amneal Pharms, Aurobindo Pharma, Avanthi Inc, Chartwell Rx, Glenmark Pharms Ltd, Hetero Labs Ltd Iii, Inwood Labs, Jubilant Generics, Mylan, Novast Labs, Sandoz, Watson Labs Inc, Zydus Pharms, Teva, Zyla Life Sciences, Ani Pharms, Chartwell Molecules, Cycle, Duramed Pharms Barr, Halsey, Heritage, Heritage Pharma, Ivax Sub Teva Pharms, Mutual Pharm, Parke Davis, Pioneer Pharms, Rising, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, Watson Labs, Zydus Lifesciences, Genus, Fresenius Kabi Usa, Cosette, Hikma, Novitium Pharma, Recordati Rare, Hospira, Navinta Llc, and West-ward Pharms Int, and is included in seventy-two NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Indomethacin has thirty-seven patent family members in twenty-one countries.
There are fifteen drug master file entries for indomethacin. Thirty-two suppliers are listed for this compound.
Summary for indomethacin
International Patents: | 37 |
US Patents: | 3 |
Tradenames: | 6 |
Applicants: | 43 |
NDAs: | 72 |
Drug Master File Entries: | 15 |
Finished Product Suppliers / Packagers: | 32 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 178 |
Drug Prices: | Drug price trends for indomethacin |
Drug Sales Revenues: | Drug sales revenues for indomethacin |
What excipients (inactive ingredients) are in indomethacin? | indomethacin excipients list |
DailyMed Link: | indomethacin at DailyMed |
Recent Clinical Trials for indomethacin
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Mostar | Phase 2/Phase 3 |
GlaxoSmithKline | Phase 1 |
Moti Lal Nehru Medical College | N/A |
Pharmacology for indomethacin
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for indomethacin
US Patents and Regulatory Information for indomethacin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jubilant Generics | INDOMETHACIN | indomethacin | CAPSULE, EXTENDED RELEASE;ORAL | 202706-001 | Oct 5, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Genus | TIVORBEX | indomethacin | CAPSULE;ORAL | 204768-001 | Feb 24, 2014 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Jubilant Generics | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 205215-001 | Aug 25, 2017 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Navinta Llc | INDOMETHACIN SODIUM | indomethacin sodium | INJECTABLE;INJECTION | 206561-001 | Jul 19, 2017 | AP | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Ivax Sub Teva Pharms | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 018730-002 | May 4, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for indomethacin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Zyla | INDOCIN SR | indomethacin | CAPSULE, EXTENDED RELEASE;ORAL | 018185-001 | Feb 23, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Zyla Life Sciences | INDOCIN | indomethacin | SUPPOSITORY;RECTAL | 017814-001 | Aug 13, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Zyla Life Sciences | INDOCIN | indomethacin | SUPPOSITORY;RECTAL | 017814-001 | Aug 13, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for indomethacin
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Tunisia | 2011000544 | A NOVEL FORMUALTION OF INDOMETHACIN | ⤷ Sign Up |
Singapore | 175315 | A NOVEL FORMULATION OF INDOMETHACIN | ⤷ Sign Up |
Brazil | PI1014275 | nova formulação de indometacina | ⤷ Sign Up |
Ukraine | 106231 | РАЗОВАЯ ДОЗА ФАРМАЦЕВТИЧЕСКОЙ КОМПОЗИЦИИ ИНДОМЕТАЦИНА (ВАРИАНТЫ);РАЗОВА ДОЗА ФАРМАЦЕВТИЧНОЇ КОМПОЗИЦІЇ ІНДОМЕТАЦИНУ (ВАРІАНТИ) (SINGLE DOSE OF INDOMETHACIN-CONTAINING COMPOSITION) | ⤷ Sign Up |
Australia | 2010239081 | A novel formulation of indomethacin | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.